InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,131.60
(
-0.23%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.32
(
-0.18%
)
Bitcoin
60,685.59
(
-0.20%
)
Post# of 21373
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dabullishbear

Send PM Follow Ignore
Followers 23
Posts 1725
Boards Moderated 0
Alias Born 09/03/2015

dabullishbear

Re: dabullishbear post# 16937

Friday, 03/09/2018 11:26:39 AM

Friday, March 09, 2018 11:26:39 AM

Post# of 21373
It doesnt matter even a fraction of a percent if Wen Chen is an advisor or not. Prolanta has already been invented and under the ownership of Oncolix. The science and effectiveness of Prolanta is no way shape or form dependent upon Wen Chen's involvement. If Prolanta is a success, Wen Chen doesnt need to be involved as he will collect licensing royalties for as long as Prolanta is used as a treatment.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up